Compare Bio Protocol (BIO) vs Hive (HIVE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Hive — how do they compare? Bio Protocol trades at Rp431.47 (market cap Rp982,16M, Rp150,34M 24h volume), while Hive trades at Rp689.42 (market cap Rp395,82M, Rp9,21M 24h volume). The key difference: Bio Protocol is far larger — about 2.5× Hive's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Hive's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Hive for 42 Days on average.
| BIO | HIVE | |
|---|---|---|
Market Cap | Rp982,16M | Rp395,82M |
Volume (24h) | Rp150,34M | Rp9,21M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 574,8M HIVE |
Typical Hold Time | 18 Days | 42 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
HIVE is currently trading at Rp706.45 with a bearish technical outlook, showing mixed signals between oversold RSI readings and strong selling pressure on moving averages. The token faces immediate support at Rp693 and resistance at Rp716, with recent price action indicating consolidation near lower levels. Recent ecosystem developments include ongoing protocol optimizations and community governance discussions, though no major network upgrades have been announced recently.
Overall outlook remains cautious with potential for short-term rebounds given oversold conditions, but structural bearish momentum persists. Key opportunities include potential technical bounces from support levels, while major risks involve continued selling pressure and broader crypto market volatility. Investors should monitor network activity metrics and trading volume patterns for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Hive
HIVE is a decentralized information sharing network with an accompanying blockchain-based financial ledger built on the Delegated Proof of Stake (DPoS) protocol. Hive is developed to store vast amounts of content and to make it available for time-based monetization. Examples of use include social media with monetized rewards for content producers, interactive games, identity management, polling systems, and micro-loans.
Read more on HIVE →
